Nature-based IVR reduces anxiety and distress in breast cancer patients with low certainty evidence
Nature-based virtual reality may ease anxiety and distress for breast cancer patients
This systematic review and meta-analysis evaluated nature-based immersive virtual reality (IVR) for breast cancer patients. The pooled analy…
A new analysis suggests nature-based virtual reality could help reduce anxiety and distress in breast cancer patients, offering a new tool f…
Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma shows TTF-1 expression and Ki-67 less than 10% in reported cases
Thyroid-like cancer in the nose shows unique markers
This case report with literature review describes thyroid-like low-grade nasopharyngeal papillary adenocarcinoma (TL-LGNPPA). The authors sy…
A review of rare thyroid-like cancers in the nose highlights specific markers that help doctors distinguish this condition from other tumors…
FDA Approves Truqap (capivasertib) for HR+/HER2- Advanced Breast Cancer with PIK3CA/AKT1/PTEN Alterations
FDA approves new drug Truqap for certain advanced breast cancers.
The FDA approved Truqap (capivasertib) in combination with fulvestrant for HR-positive, HER2-negative advanced or metastatic breast cancer w…
The FDA approved Truqap (capivasertib) with fulvestrant for adults with HR-positive, HER2-negative advanced breast cancer that has specific …
FDA Approves Decnupaz for Blastic Plasmacytoid Dendritic Cell Neoplasm
FDA approves new drug Decnupaz for rare blood cancer BPDCN
FDA approved Decnupaz (decnupaz) for adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). It is a CD123-directed antibo…
The FDA approved Decnupaz for adults with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and aggressive blood cancer. This tar…
FDA Approves Imfinzi (durvalumab) for Resectable NSCLC and Other Indications
FDA approves Imfinzi for multiple cancers including lung and liver.
The FDA approved Imfinzi (durvalumab) for multiple indications including resectable NSCLC, unresectable Stage III NSCLC, LS-SCLC, ES-SCLC, B…
The FDA approved Imfinzi (durvalumab) for several cancers, including lung, liver, bile duct, and stomach cancers. It is used alone or with o…
FDA Approves Columvi (glofitamab) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
FDA approves new drug Columvi for adults with hard-to-treat lymphoma.
The FDA approved Columvi (glofitamab) for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or large B-cell lymphoma …
The FDA approved Columvi (glofitamab) for adults with relapsed or refractory diffuse large B-cell lymphoma after two or more treatments. Thi…
FDA Approves Hepzato (melphalan) for Uveal Melanoma with Hepatic Metastases
FDA approves new liver treatment for rare eye cancer that spread to liver.
FDA approved Hepzato (melphalan) as a liver-directed treatment for adult patients with uveal melanoma and unresectable hepatic metastases af…
The FDA approved Hepzato (melphalan) for adults with uveal melanoma that has spread to the liver. It is for patients with limited liver invo…
Immunotherapy improves complete response but lacks overall response benefit in HR+ breast cancer
Immunotherapy shows mixed results for hormone-positive breast cancer patients
This systematic review and meta-analysis evaluated immunotherapy in patients with hormone receptor-positive and human epidermal growth facto…
A large analysis found immunotherapy did not improve overall survival but did increase side effects for hormone-positive breast cancer patie…
Meta-analysis quantifies pre-diagnosis weight loss in pancreatic cancer patients
Pancreatic cancer patients lost nearly 6 kg before diagnosis in this large review
A systematic review of 25,971 patients found pre-diagnosis weight loss averaging 5.9 kg and a 2.5 kg/m² BMI decrease, aiding early detection…
A review of 25,971 people found they lost about 6 kg and saw BMI drop before pancreatic cancer was diagnosed.
Physical exercise improves cognitive function in patients with cancer, umbrella review finds
Exercise improves thinking skills in cancer patients, review finds
An umbrella review of 7536 patients with cancer found that physical exercise, typically supervised 12-week aerobic programs at moderate inte…
A new review of 18 studies finds that physical exercise can help cancer patients sharpen their thinking and processing speed.
Systematic review shows robotic colorectal surgery lowers CRP and complications versus laparoscopy in adult patients
Robotic surgery shows lower inflammation markers in colorectal cancer patients
This meta-analysis of 1706 adult patients undergoing elective abdominal surgery reveals that robotic techniques significantly reduce postope…
A meta-analysis found robotic surgery linked to lower inflammation and fewer complications compared to laparoscopy in colorectal cancer case…
Robotic TME reduces CRM positivity and three-year recurrence in mid or low rectal cancer
Robotic surgery shows benefits for rectal cancer
This systematic review and meta-analysis of randomised trials in mid or low rectal adenocarcinoma found robotic total mesorectal excision re…
A review of trials finds robotic surgery may improve key outcomes for rectal cancer patients compared to laparoscopic surgery.